Arvinas, Inc. (ARVN) stock
ARVNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$6.82+0.05 (+0.74%)
Close on Nov 17, 2026Market cap $445.93MP/E 42.6Yield –
Arvinas enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Arvinas's enterprise value was -$116.18M on Nov 11, 2026, against $104.02M a year earlier. Over the last 5 years it ranged from -$555.62M to $2.79B, with a median of $210.85M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$116.18M | -320.5% |
| 2025 | Dec 31, 2025 | $52.69M | -73.1% |
| 2024 | Dec 31, 2024 | $196.18M | -84.5% |
| 2023 | Dec 29, 2023 | $1.27B | +130.1% |
| 2022 | Dec 30, 2022 | $550.27M | -80.2% |
| 2021 | Dec 31, 2021 | $2.79B | -11.8% |
| 2020 | Dec 31, 2020 | $3.16B | +169.8% |
| 2019 | Dec 31, 2019 | $1.17B | – |
| 2018 | Dec 31, 2018 | -$40.26M | – |
See a number that looks wrong?